Abstract:Abstract Background Inflammatory bowel diseases (IBD), encompassing ulcerative colitis (UC) and Crohn’s disease (CD), are associated with an increased risk of metabolic bone diseases (MBD). The aim of the current study was to evaluate for the occurrence of MBD in which all patients with newly diagnosed IBD are offered a Dual-energy X-ray absorptiometry (DXA) scan. Secondly, we aimed to identify risk factors for development of MBD. Methods All adult patients with newly diagnosed IBD within a catchment area corresponding to ~20% of the Danish population have since May 2021 been enrolled in an ongoing prospective population-based inception cohort, IBD Prognosis Study. Herein, all participants were, as part of the initial work-up, invited to a DXA scan at IBD diagnosis. A T-score< −2.5 standard deviations (SD) was diagnostic for osteoporosis, while a T-score between –1 and –2.5 defined osteopenia. Multivariate analyses adjusted findings for age, gender, and medication differences. Results A total of 316 patients with newly diagnosed IBD (UC: 178, CD: 117, unclassified IBD (IBDU): 21) received a DXA scan within 90 days (interquartile range (IQR) 51-139 days). Baseline characteristics of the population were similar to those previously described for newly diagnosed IBD. In total, 48 (27%, females (F): 26%, males (M): 28%) and 17 (10%, F: 14%, M: 5%) patients with UC were found to have osteopenia and osteoporosis, resp. The corresponding numbers for CD were 23 (20%, F: 15%, M: 24%) and nine (8%, F: 7%, M: 9%). Subgroup analysis showed a high occurrence of osteopenia in both UC and CD regardless of age group (Table 1). No difference between UC and CD was observed in terms of the risk of osteopenia (adjusted odds ratio (aOR)=1.86 (95% confidence interval (CI) 0.99-3.60) or osteoporosis (OR=1.42 (95% CI 0.53-4.08)). Low albumin level (<36 g/L) was the only factor associated with osteopenia in patients with UC (aOR=2.57 (95% CI 1.05-6.53). In patients with CD, no risk factors were identified. However, the risk of osteoporosis was independently associated with age higher than 65 years in both UC (aOR=13.4 (95% CI 3.78-51.36)) and CD (aOR=6.39 (95% CI 1.09-35.47)), while female gender was not relevant (UC: aOR=2.63 (95% CI 0.75-10.98), CD: (aOR=0.47 (95% CI 0.08-2.20)). Finally, the risk of MBD was not associated with IBD phenotype, medications, or patient-reported or endoscopic severity. Conclusion To our knowledge, the current study is the first evaluation of DXA scans as a screening tool for patients with newly diagnosed IBD in a population-based setting. We found a high incidence of osteopenia affecting every fourth patient at IBD diagnosis. These findings are concerning given the high risk of repeated need for systemic steroids in this patient population.

P506 Prevalance of the osteoporosis/osteopenia and related factors in patients with inflammatory bowel disease : An observational single-center study

Assessment of Bone Metabolism in Patients with Inflammatory Bowel Disease

The Risk Factor for Low Bone Mineral Density in Patients with Inflammatory Bowel Disease

P617 Persistent active inflammation may predict non-improvement in bone mass density in patients with Crohn's disease

Risk Factors for Osteoporosis among Patients with Inflammatory Bowel Disease—Do We Already Know Everything?

Bone Mineral Density is Negatively Correlated with Ulcerative Colitis: a Systematic Review and Meta-Analysis

Systematic review of the prevalence and development of osteoporosis or low bone mineral density and its risk factors in patients with inflammatory bowel disease

Risk Factors for Worsening of Bone Loss in Patients Newly Diagnosed with Inflammatory Bowel Disease

P311 Prevalence and impact of sarcopenia in patients with inflammatory bowel diseases: a prospective cohort study

P1116 Risk of fractures in children and adults with inflammatory bowel disease: A report from the epi-IIRN

OP38 Should all patients with newly diagnosed inflammatory bowel diseases be screened for metabolic bone disease? Results from a Danish population-based inception cohort study

Re-evaluating osteoporosis and fracture risk in Crohn’s disease patients in the era of TNF-alpha inhibitors

Bone Mineral Density and Its Influential Factors in Chinese Patients with Newly Diagnosed Crohn's Disease.

Associations of Lifestyle Factors with Osteopenia and Osteoporosis in Polish Patients with Inflammatory Bowel Disease

The Efficacy and Safety of Bisphosphonates for Osteoporosis or Osteopenia in Crohn's Disease: a Meta-Analysis.

Evaluation of Bone Mineral Density and Body Compositions Interrelation in Young and Middle-Aged Male Patients with Crohn's Disease by Quantitative Computed Tomography.

Osteonecrosis in patients with inflammatory bowel disease: a systematic review and meta-analysis

Osteoporosis Complications in Crohn's Disease Patients: Factors, Pathogenesis, and Treatment Outlines

Factors associated with decreased bone mineral density in patients with inflammatory bowel disease

Lack of relationship of calcium and vitamin D intake to bone mineral density in premenopausal women with inflammatory bowel disease

P1029 Prevalance and risk factors of thromboembolism in Inflammatory Bowel Disease